Gene expression profiles of murine fatty liver induced by the administration of valproic acid - PubMed (original) (raw)
. 2007 Apr 1;220(1):45-59.
doi: 10.1016/j.taap.2006.12.016. Epub 2006 Dec 22.
Affiliations
- PMID: 17292431
- DOI: 10.1016/j.taap.2006.12.016
Gene expression profiles of murine fatty liver induced by the administration of valproic acid
Min-Ho Lee et al. Toxicol Appl Pharmacol. 2007.
Abstract
Valproic acid (VPA) has been used as anticonvulsants, however, it induces hepatotoxicity such as microvesicular steatosis and necrosis in the liver. To explore the mechanisms of VPA-induced steatosis, we profiled the gene expression patterns of the mouse liver that were altered by treatment with VPA using microarray analysis. VPA was orally administered as a single dose of 100 mg/kg (low-dose) or 1000 mg/kg (high-dose) to ICR mice and the animals were killed at 6, 24, or 72 h after treatment. Serum alanine aminotransferase and aspartate aminotransferase levels were not significantly altered in the experimental animals. However, symptoms of steatosis were observed at 72 h with low-dose and at 24 h and 72 h with high-dose. After microarray data analysis, 1910 genes were selected by two-way ANOVA (P<0.05) as VPA-responsive genes. Hierarchical clustering revealed that gene expression changes depended on the time rather than the dose of VPA treatment. Gene profiling data showed striking changes in the expression of genes associated with lipid, fatty acid, and steroid metabolism, oncogenesis, signal transduction, and development. Functional categorization of 1156 characteristically up- and down-regulated genes (cutoff >1.5-fold) revealed that 60 genes were involved in lipid metabolism that was interconnected with biological pathways for biosynthesis of triglyceride and cholesterol, catabolism of fatty acid, and lipid transport. This gene expression profile may be associated with the known steatogenic hepatotoxicity of VPA and it may provide useful information for prediction of hepatotoxicity of unknown chemicals or new drug candidates through pattern recognition.
Similar articles
- Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.
Silva MF, Aires CC, Luis PB, Ruiter JP, IJlst L, Duran M, Wanders RJ, Tavares de Almeida I. Silva MF, et al. J Inherit Metab Dis. 2008 Apr;31(2):205-16. doi: 10.1007/s10545-008-0841-x. Epub 2008 Apr 4. J Inherit Metab Dis. 2008. PMID: 18392741 Review. - Gene expression profiles of murine fatty liver induced by the administration of methotrexate.
Lee MH, Hong I, Kim M, Lee BH, Kim JH, Kang KS, Kim HL, Yoon BI, Chung H, Kong G, Lee MO. Lee MH, et al. Toxicology. 2008 Jul 10;249(1):75-84. doi: 10.1016/j.tox.2008.04.011. Epub 2008 Apr 22. Toxicology. 2008. PMID: 18502557 - Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH, Kim M, Lee BH, Kim JH, Kang KS, Kim HL, Yoon BI, Chung H, Kong G, Lee MO. Lee MH, et al. Toxicol Appl Pharmacol. 2008 Feb 1;226(3):271-84. doi: 10.1016/j.taap.2007.09.014. Epub 2007 Sep 22. Toxicol Appl Pharmacol. 2008. PMID: 17963808 - Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline.
Yin HQ, Kim M, Kim JH, Kong G, Lee MO, Kang KS, Yoon BI, Kim HL, Lee BH. Yin HQ, et al. Toxicol Sci. 2006 Nov;94(1):206-16. doi: 10.1093/toxsci/kfl078. Epub 2006 Aug 17. Toxicol Sci. 2006. PMID: 16917069 - Linking nutrition to genomics.
Bauer M, Hamm A, Pankratz MJ. Bauer M, et al. Biol Chem. 2004 Jul;385(7):593-6. doi: 10.1515/BC.2004.073. Biol Chem. 2004. PMID: 15318807 Review.
Cited by
- Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.
Punapart M, Eltermaa M, Oflijan J, Sütt S, Must A, Kõks S, Schalkwyk LC, Fernandes C, Vasar E, Soomets U, Terasmaa A. Punapart M, et al. PPAR Res. 2014;2014:349525. doi: 10.1155/2014/349525. Epub 2014 Apr 1. PPAR Res. 2014. PMID: 24799886 Free PMC article. - Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
López-Pascual E, Rienda I, Perez-Rojas J, Rapisarda A, Garcia-Llorens G, Jover R, Castell JV. López-Pascual E, et al. Int J Mol Sci. 2024 May 10;25(10):5203. doi: 10.3390/ijms25105203. Int J Mol Sci. 2024. PMID: 38791241 Free PMC article. Review. - A proteomic analysis of the functional effects of fatty acids in NIH 3T3 fibroblasts.
Magdalon J, Hatanaka E, Romanatto T, Rodrigues HG, Kuwabara WM, Scaife C, Newsholme P, Curi R. Magdalon J, et al. Lipids Health Dis. 2011 Nov 24;10:218. doi: 10.1186/1476-511X-10-218. Lipids Health Dis. 2011. PMID: 22114894 Free PMC article. - Toxicogenomic biomarkers for liver toxicity.
Kiyosawa N, Ando Y, Manabe S, Yamoto T. Kiyosawa N, et al. J Toxicol Pathol. 2009 Mar;22(1):35-52. doi: 10.1293/tox.22.35. Epub 2009 Apr 6. J Toxicol Pathol. 2009. PMID: 22271975 Free PMC article. - Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.
Silva MF, Aires CC, Luis PB, Ruiter JP, IJlst L, Duran M, Wanders RJ, Tavares de Almeida I. Silva MF, et al. J Inherit Metab Dis. 2008 Apr;31(2):205-16. doi: 10.1007/s10545-008-0841-x. Epub 2008 Apr 4. J Inherit Metab Dis. 2008. PMID: 18392741 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources